PHASTAR attended BIO conference.
PHASTAR attended last week's BIO conference in Philadelphia, attended by over 15000 pharma and biotech professionals. There were many heart-warming stories of successful individuals and organisations making progress in the fight against various diseases. Talk of innovation in biotech was rife, such as combination immunotherapy, and how big data will impact drug development. Another hightlight was Bill Clinton giving a talk alongside the conference calling for "disruptors" in biotech.
The BIO conference confirmed that PHASTAR are moving in the right direction with our current expansion plans to the US. In the state of New Jersey alone, one presented noted that there are 3100 biotech and pharma companies, a number that exceeds biotech companies in the UK alone. PHASTAR's expansion plans are well underway, and we plan to have a US office open by the end of 2015. We will also attend JSM in Seattle in August to further learn about the US market for biostatistical services.
During the conference, we met over 30 companies, through the formal partnering system provided by BIO, but also through informal meetings at the numerous networking events, such as the conference closing event kindly sponsored by J&J. Whilst there are so many biotech companies attending the conference, it is also obvious that there is a need for improved statistical support in this arena. Companies are often presenting their results to attract investors and there were many statistical problems in the way that the data were presented.